国家医保谈判药品落地情况研究——基于5市17种国谈抗癌药使用及报销数据的分析

Research on the Accessibility of National Medical Insurance Negotiation Drugs--An Analysis Based on the Usage and Reimbursement Data of 17 National Negotiated Anticancer Drugs in Five Cities

通过对比5市17种国谈抗癌药的使用及报销数据,分析国谈药落地情况及其影响因素。为促进国谈药落地,要提高医疗机构配备国谈药的积极性;加快推动“双通道”管理政策落地,发挥药店供药作用;完善多层次医疗保障制度,提高国谈药报销水平;加强医保基金监管,确保安全、合理用药。

By comparing the use and reimbursement data of 17 anticancer drugs,the implementation of the drugs and their influencing factors were analyzed.In order to promote the implementation of national negotiated drugs,it is necessary to increase the enthusiasm of medical institutions to deploy national negotiated drugs,accelerate the implementation of the dual-channel management policy,give play to the role of pharmacies in drug supply,improve the multi-level medical security system,improve the reimbursement level of national negotiated drugs,strengthen the supervision of medical insurance funds,and ensure safe and rational use of drug.